**Methotrexate Enhances Syk Inhibitor Efficacy by Reducing Cytokine-Driven B-Cell Priming**
In rheumatoid arthritis (RA), B cells contribute to chronic inflammation through autoantibody production, antigen presentation, and cytokine release. While Syk inhibitors like PRT062607 effectively suppress BCR signaling and downstream functional…